Eureka Therapeutics Announces Presentations at Upcoming Industry Conferences
September 13, 2017 08:00 AM Eastern Daylight Time EMERYVILLE, Calif.–(BUSINESS WIRE)– Eureka Therapeutics, Inc., a clinical stage biotechnology company focused on developing novel T-cell immunotherapies for